Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation
- PMID: 3291987
Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation
Abstract
We evaluated serially by cytogenetics the blood and marrow chimerism of 38 leukemic recipients of HLA-matched bone marrow transplants (BMT) who were prepared by high doses of alkylating agents and fractionated total-body irradiation (2.2 Gy X 5). Donor or host mitoses were identified by examination of sex chromosomes in 32 patients or by evaluation of the polymorphism of other chromosomes after specific banding in six patients. Twenty-four patients were recipients of untreated BMT, and 14 were recipients of T-cell-depleted BMT. In the 24 patients who received untreated BMT, all showed successful engraftment, and only three had a transient mixed chimera. In the 14 recipients of T-cell-depleted BMTs, four rejected their grafts, and seven had mixed chimeras; these mixed chimeras were more frequent in blood lymphocytes than in marrow cells and could be detected up to 26 months after BMT. This high frequency of partial chimerism after T-cell-depleted BMT by comparison with a control group suggests that the donor's T cells play an important role in the eradication of host residual hematopoiesis after allogeneic BMT.
Similar articles
-
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.Blood. 1992 Dec 15;80(12):3235-41. Blood. 1992. PMID: 1467526
-
Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia.Blood. 1991 Dec 1;78(11):3103-6. Blood. 1991. PMID: 1954396
-
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts.Blood. 1985 Sep;66(3):664-72. Blood. 1985. PMID: 3896348
-
Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.Blood. 1995 Nov 1;86(9):3590-7. Blood. 1995. PMID: 7579468 Review.
-
Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.Hum Immunol. 1997 Feb;52(2):155-61. doi: 10.1016/S0198-8859(96)00290-X. Hum Immunol. 1997. PMID: 9077564 Review.
Cited by
-
Effects of mixed chimerism and immune modulation on GVHD, disease recurrence and survival after HLA-identical marrow transplantation for hematologic malignancies.Korean J Intern Med. 2000 Dec;15(3):224-31. doi: 10.3904/kjim.2000.15.3.224. Korean J Intern Med. 2000. PMID: 11242811 Free PMC article.
-
Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.Proc Natl Acad Sci U S A. 1990 Jan;87(2):563-7. doi: 10.1073/pnas.87.2.563. Proc Natl Acad Sci U S A. 1990. PMID: 2405384 Free PMC article.
-
Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.J Exp Med. 1993 Aug 1;178(2):703-12. doi: 10.1084/jem.178.2.703. J Exp Med. 1993. PMID: 8101864 Free PMC article.
-
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.Blood. 2011 Jun 30;117(26):7007-13. doi: 10.1182/blood-2011-02-337725. Epub 2011 Apr 25. Blood. 2011. PMID: 21518931 Free PMC article.
-
Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation.Histochem Cell Biol. 1996 Nov;106(5):481-5. doi: 10.1007/BF02473310. Histochem Cell Biol. 1996. PMID: 8950606
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials